The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ruxolitinib safety experience in the polycythemia vera clinical trial program.
 
Srdan Verstovsek
Research Funding - Incyte (Inst)
 
Ruben A. Mesa
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Celgene; CTI; Gilead Sciences; Incyte
 
Bruno Martino
No Relationships to Disclose
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Incyte; Novartis; Shire
Research Funding - AOP Orphan Pharmaceuticals; Novartis
 
Mark M. Jones
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Shui He
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Dany Habr
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Iulian Alecu
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Alessandro M. Vannucchi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis; Shire
Research Funding - Novartis (Inst)